Pepgen announces upcoming data presentations at the 2023 american academy of neurology annual meeting

Boston, april 17, 2023 (globe newswire) -- pepgen inc. (nasdaq: pepg), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that it will present at the 2023 american academy of neurology (aan) annual meeting, taking place on april 22-27, 2023 in boston, massachusetts.
PEPG Ratings Summary
PEPG Quant Ranking